Dr. Sanjay Gupta on the Joe Rogan Experience #1718, fact-checked

What the evidence shows: Gupta's claim reflects the reactogenicity data collected in the original COVID-19 vaccine trials, which used roughly a 42-day (two-month) solicited-adverse-event window and found that common side effects like fever, fatigue, and injection-site pain onset within days and resolve quickly. However, rarer serious adverse events, most notably myocarditis and pericarditis after mRNA vaccines, were not identified within that short trial window because the trials were not large enough to detect low-frequency events; they emerged only after millions of people were vaccinated, through passive and active post-marketing surveillance. A large Israeli study found myocarditis after the BNT162b2 vaccine occurred at roughly 1 case per 26,000 vaccinated young men, with onset typically within days of the (usually second) dose, but the safety signal itself was detected through national-level surveillance conducted after authorization, not within the original clinical-trial follow-up period. The FDA continues to run dedicated post-authorization passive and active surveillance systems specifically because trial-length windows are too short and trials too small to catch rare adverse events. So while individual side effects, once they occur, tend to show up within days to weeks (consistent with a 42-day framing), the claim that a 42-day window is sufficient to capture significant side effects overall is misleading, since detection of rare but serious events required larger-scale, longer-running surveillance beyond the original trial period.

What the evidence shows: Rogan's figure traces to a 2021 medRxiv preprint by Høeg, Krug, Stevenson, and Mandrola ("SARS-CoV-2 mRNA Vaccination-Associated Myocarditis in Children Ages 12-17"), which was never peer-reviewed and compared the rate of myocarditis diagnoses following vaccination to the rate of hospitalization for COVID-19 for any cause in the same age group. Public health researchers, including those behind CDC/ACIP risk-benefit analyses, criticized this comparison as an apples-to-oranges framing because it pits a vaccine harm against overall COVID hospitalization risk rather than against the risk of myocarditis or other cardiac injury caused by SARS-CoV-2 infection itself, which multiple studies (including a 23-million-person Nordic cohort study) and CDC data found to be several times higher than vaccine-associated myocarditis risk. Peer-reviewed data, including the Nordic cohort study, consistently show that myocarditis risk after SARS-CoV-2 infection exceeds myocarditis risk after vaccination, particularly in young males, and that the large majority of vaccine-associated myocarditis cases are mild and self-resolving. The specific "4 to 6 times more likely" statistic cited on air did not come from a peer-reviewed, published study and reflects a comparison method considered misleading by public health researchers because it does not compare like-for-like cardiac outcomes.

What the evidence shows: In September 2009, Pfizer and its subsidiary Pharmacia & Upjohn agreed to pay $2.3 billion to resolve criminal and civil liability, a sum federal authorities described at the time as the largest health care fraud settlement in U.S. history. The case centered specifically on illegal off-label promotion and marketing of several drugs, most notably the painkiller Bextra, rather than "fraudulent advertising" in a generic sense; a subsidiary pleaded guilty to a felony misbranding charge. Gupta's core figures ($2.3 billion, "largest ever") match the contemporaneous record, though describing the conduct simply as "fraudulent claims, fraudulent advertising" omits that the settlement resolved False Claims Act allegations tied to off-label marketing across multiple products, not a single fraudulent-advertising episode. The settlement was later surpassed by GlaxoSmithKline's roughly $3 billion 2012 settlement, meaning Pfizer's case was the largest at the time it occurred but is no longer the largest health care fraud settlement overall. Overall, the dollar figure and contemporaneous "largest ever" framing are well-supported, though the claim omits a time qualifier and simplifies the underlying off-label-promotion conduct.

What the evidence shows: The claim that Uttar Pradesh's mass ivermectin distribution "knocked COVID down to almost nothing" originated with proponents such as Dr. Pierre Kory and spread widely online, but fact-checkers and epidemiologists found no scientific basis for crediting ivermectin with the state's case decline. Uttar Pradesh's government says it began distributing ivermectin as early as August 2020, well before the 2021 Delta-wave surge and collapse, and the drug did not prevent that wave. Researchers who examined all-cause mortality data for the state found implausible patterns, such as populous districts reporting no deaths at all for months, suggesting the underlying case and death data are too unreliable to support any causal claim about what drove the decline. A Cochrane systematic review of the available trial evidence found no evidence to support using ivermectin to treat or prevent COVID-19. Public health researchers who studied Uttar Pradesh's actual pandemic response describe inconsistent and rapidly-revised treatment guidance, including on ivermectin itself, not a controlled, single-variable ivermectin campaign, further undermining the causal narrative.

What the evidence shows: Two separate episodes are often conflated under the "deleted evidence" framing. First, in September 2019, the Wuhan Institute of Virology's public database of roughly 22,000 bat and rodent virus samples went offline; WIV virologist Shi Zhengli has said this was for security reasons following cyberattacks on staff email accounts, an explanation critics call inconsistent, but no independent investigation has confirmed the database's contents were destroyed rather than restricted from outside access. Second, in 2020 a set of early SARS-CoV-2 sequencing reads was removed from the US NIH's Sequence Read Archive at a Chinese researcher's request; virologist Jesse Bloom later recovered these sequences from cloud backups in 2021, and a 2025 peer-reviewed reexamination found the recovered data did not support claims of a deliberate cover-up, showing the sequences were largely consistent with already-published information. Neither episode has produced direct proof that evidence was destroyed as part of a deliberate cover-up: takedown and removal from public access are documented, but destruction motivated by concealing wrongdoing is not established. The full contents and current status of the WIV database remain unverified by outside researchers.